Legal & General Group
IDYA icon

Legal & General Group’s IDEAYA Biosciences IDYA Stock Holding History

Legal & General Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3M Buy
80,461
+9,969
+14% +$305K ﹤0.01% 1801
2026
Q1 		$2.35M Sell
70,492
-13,373
-16% -$449K ﹤0.01% 1848
2025
Q4 		$2.9M Sell
83,865
-8,071
-9% -$257K ﹤0.01% 1826
2025
Q3 		$2.5M Buy
91,936
+6,013
+7% +$145K ﹤0.01% 1884
2025
Q2 		$1.81M Buy
85,923
+1,234
+1% +$23.7K ﹤0.01% 2008
2025
Q1 		$1.39M Buy
84,689
+2,247
+3% +$47.9K ﹤0.01% 2062
2024
Q4 		$2.12M Buy
82,442
+12,372
+18% +$350K ﹤0.01% 1953
2024
Q3 		$2.22M Buy
70,070
+1,724
+3% +$65.4K ﹤0.01% 1922
2024
Q2 		$2.4M Buy
68,346
+8,573
+14% +$340K ﹤0.01% 1856
2024
Q1 		$2.62M Buy
59,773
+10,321
+21% +$444K ﹤0.01% 1808
2023
Q4 		$1.76M Sell
49,452
-1,122
-2% -$33.5K ﹤0.01% 2007
2023
Q3 		$1.36M Buy
50,574
+2,415
+5% +$61.2K ﹤0.01% 2064
2023
Q2 		$1.13M Buy
48,159
+32,758
+213% +$674K ﹤0.01% 2169
2023
Q1 		$211K Buy
15,401
+826
+6% +$13.8K ﹤0.01% 2566
2022
Q4 		$265K Buy
14,575
+1,182
+9% +$19.9K ﹤0.01% 2510
2022
Q3 		$199K Buy
13,393
+3,935
+42% +$51.1K ﹤0.01% 2630
2022
Q2 		$130K Sell
9,458
-383
-4% -$4.26K ﹤0.01% 2779
2022
Q1 		$110K Buy
9,841
+62
+0.6% +$914 ﹤0.01% 2842
2021
Q4 		$231K Buy
9,779
+6,462
+195% +$150K ﹤0.01% 2671
2021
Q3 		$84K Buy
3,317
+375
+13% +$8.76K ﹤0.01% 2882
2021
Q2 		$62K Buy
2,942
+1,333
+83% +$27.4K ﹤0.01% 2886
2021
Q1 		$38K Buy
1,609
+168
+12% +$3.24K ﹤0.01% 2910
2020
Q4 		$20K Hold
1,441
– – ﹤0.01% 3090
2020
Q3 		$18K Sell
1,441
-173
-11% -$2.14K ﹤0.01% 3003
2020
Q2 		$23K Buy
+1,614
New +$12.7K ﹤0.01% 3006

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Legal & General Group's IDYA Position: Q2 2026 in Review

Legal & General Group increased its IDEAYA Biosciences (IDYA) stake by 14% in Q2 2026, buying an estimated $305K and bringing the position to 80,461 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

Legal & General Group first reported a position in IDYA in Q2 2020 and has held it in 25 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Legal & General Group held 80,461 shares of IDEAYA Biosciences worth $3M as of Q2 2026.
  • Legal & General Group bought 9,969 IDEAYA Biosciences shares in Q2 2026, an estimated $305K.
  • IDEAYA Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1801 holding.
  • Legal & General Group first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 25 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.